These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35903906)

  • 41. [Familial Mediterranean fever].
    Georgin-Lavialle S; Hentgen V; Stankovic Stojanovic K; Bachmeyer C; Rodrigues F; Savey L; Abbara S; Conan PL; Fraisse T; Delplanque M; Rouet A; Sbeih N; Koné-Paut I; Grateau G
    Rev Med Interne; 2018 Apr; 39(4):240-255. PubMed ID: 29526329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can colchicine response be predicted in familial Mediterranean fever patients?
    Özçakar ZB; Elhan AH; Yalçınkaya F
    Rheumatology (Oxford); 2014 Oct; 53(10):1767-72. PubMed ID: 24764265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever.
    Verrecchia E; Sicignano LL; La Regina M; Nucera G; Patisso I; Cerrito L; Montalto M; Gasbarrini A; Manna R
    Mediators Inflamm; 2017; 2017():7461426. PubMed ID: 29379228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protracted arthritis in a Japanese patient with familial Mediterranean fever.
    Migita K; Hisanaga S; Izumi Y; Kawahara C; Shigemitsu Y; Iwanaga N; Araki T; Kamata M; Izumi M; Kumagai K; Kawakami A
    Mod Rheumatol; 2017 Sep; 27(5):905-909. PubMed ID: 25800639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
    Gül A; Ozdogan H; Erer B; Ugurlu S; Kasapcopur O; Davis N; Sevgi S
    Arthritis Res Ther; 2015 Sep; 17(1):243. PubMed ID: 26337145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency, characteristics, and clinical determinants of 'prodrome' in familial Mediterranean fever patients.
    Babaoglu H; Atas N; Varan O; Satis H; Bilici Salman R; Guler A; Karadeniz H; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Scand J Rheumatol; 2020 Mar; 49(2):154-158. PubMed ID: 31478409
    [No Abstract]   [Full Text] [Related]  

  • 47. Genotype-phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patients.
    Beshlawy AE; Zekri AER; Ramadan MS; Selim YMM; Abdel-Salam A; Hegazy MT; Ragab L; Gaggiano C; Cantarini L; Ragab G
    Clin Rheumatol; 2022 May; 41(5):1511-1521. PubMed ID: 34988684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
    Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
    Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients.
    Varan O; Kucuk H; Babaoglu H; Atas N; Salman RB; Satis H; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Clin Rheumatol; 2019 Apr; 38(4):1125-1130. PubMed ID: 30535829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients.
    Bodakçi E; Yaşar Bilge NŞ; Ataş N; Armağan B; Satış H; Sarı A; Bilici Salman R; Kübra Yardımcı G; Babaoğlu H; Kılıç L; Öztürk MA; Göker B; Haznedaroğlu Ş; Kalyoncu U; Tufan A; Kaşifoğlu T
    Turk J Med Sci; 2021 Aug; 51(4):1706-1711. PubMed ID: 33460325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.
    Ozen F; Silan C; Uludag A; Candan F; Silan F; Ozdemir S; Atik S; Ozdemir O
    Ren Fail; 2011; 33(9):899-903. PubMed ID: 21851199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma and platelet serotonin levels in familial Mediterranean fever.
    Onat AM; Ozçakar L; Oztürk MA; Uçar G; Ureten K; Dagli N; Kiraz S; Ertenli I; Calgüneri M
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S16-20. PubMed ID: 17949546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.
    Samuels J; Aksentijevich I; Torosyan Y; Centola M; Deng Z; Sood R; Kastner DL
    Medicine (Baltimore); 1998 Jul; 77(4):268-97. PubMed ID: 9715731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
    Erden A; Batu ED; Sarı A; Sönmez HE; Armagan B; Demir S; Fırat E; Bilginer Y; Bilgen SA; Karadağ Ö; Kalyoncu U; Kiraz S; Ertenli I; Özen S; Akdogan A
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):97-102. PubMed ID: 30418112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.
    Hara K; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Migita K; Kawakami A; Koga T
    Medicine (Baltimore); 2018 Sep; 97(38):e12305. PubMed ID: 30235678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
    Sönmez HE; Batu ED; Bilginer Y; Özen S
    Clin Rheumatol; 2017 Feb; 36(2):421-425. PubMed ID: 27679472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Canakinumab for the treatment of familial Mediterranean fever.
    Ozdogan H; Ugurlu S
    Expert Rev Clin Immunol; 2017 May; 13(5):393-404. PubMed ID: 28362189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial Mediterranean Fever (FMF): a single centre retrospective study in Amsterdam.
    Hageman IMG; Visser H; Veenstra J; Baas F; Siegert CEH
    Neth J Med; 2019 Jun; 77(5):177-182. PubMed ID: 31264586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Familial Mediterranean fever – an important disease in a globalised world].
    Wekell P; Karlsson A; Fasth A; Berg S
    Lakartidningen; 2016 Aug; 113():. PubMed ID: 27551868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.